Georgia Center for Diabetes Translation Research

The Georgia Center for Diabetes Translation Research's mission is to facilitate and grow diabetes translation research within the state of Georgia.

[Georgia Center for Diabetes Translation Research @GCDTR]

Congratulations to GCDTR /@EGDRC's @Dr_JFred on her promotion to Associate Professor at @EmoryNursing. Her research on weight-neutral lifestyle interventions for cardiometabolic disease continues to advance the field.

[Georgia Center for Diabetes Translation Research @GCDTR]

Is automated insulin delivery cost-effective for type 2? A recent study co-authored by GCDTR’s Roy W. Beck found Control-IQ+ technology yielded 0.51 additional QALYs at $59,417/QALY, well below the $100,000 threshold. https://t.co/zhg3o3SaSo

[Georgia Center for Diabetes Translation Research @GCDTR]

Tomorrow. Anne Sumner, MD, of @NIDDKgov on universally effective diabetes screening at the @egdrc & GCDTR Distinguished Lecture 2026. May 21 | 4-5 PM | Emory, Claudia Nance Rollins Building, CNR 1000. Register: https://t.co/zFsZKzh5tp

[Georgia Center for Diabetes Translation Research @GCDTR]

Can low-dose antithymocyte globulin work outside of clinical trials for type 1 diabetes? A recent study co-authored by members of GCDTR found C-peptide monitoring via modified quantitative response is feasible in practice, with HbA1c dropping 1.1%.
📎https://t.co/57pk3RkinS

[Georgia Center for Diabetes Translation Research @GCDTR]

Over half of Black adults with normal office blood pressure had high blood pressure outside the clinic. A new study co-authored by GCDTR’s @DrDaynaAJohnson , PhD, MPH, links obstructive sleep apnea risk to this hidden hypertension. Read more: https://t.co/rbNfXITSq1

[Georgia Center for Diabetes Translation Research @GCDTR]

One week away. Anne Sumner, MD, of @NIDDKgov, presents on advancing diabetes screening across populations at the EGDRC & GCDTR Distinguished Lecture 2026. May 21 | 4-5 PM | Emory. Register: https://t.co/zFsZKzhDiX

[Georgia Center for Diabetes Translation Research @GCDTR]

Are current diabetes screening tests effective across all populations? Anne Sumner, MD, of @NIDDKgov will address this at the EGDRC & GCDTR Distinguished Lecture 2026. May 21 | 4-5 PM | @EmoryUniversity Register: https://t.co/zFsZKzhDiX

[Georgia Center for Diabetes Translation Research @GCDTR]

Congratulations to GCDTR’s Liliana Aguayo, PhD, MPH, on receiving her AHA-funded grant, “Nourishing Hearts Early: Maternal DASH Diet in Pregnancy and Childhood Blood Pressure,” and first place in Original Research at the 2026 PCNA Cardiovascular Nursing Symposium.

[Georgia Center for Diabetes Translation Research @GCDTR]

Join us for our biannual Distinguished Lecture, which features & honors Anne Sumner, MD, Senior Investigator at @NIDDKgov , & discusses why universally effective diabetes screening requires knowledge of diabetes physiology. @EmoryUniversity
https://t.co/zFsZKzh5tp

[Georgia Center for Diabetes Translation Research @GCDTR]

Light during sleep, air pollution, rising temperatures, and neighborhood disadvantages are linked to poor sleep & hypertension. A new study coauthored by GCDTR’s @DrDaynaAJohnson examines the environmental drivers and identifies the greatest burden. https://t.co/f83qfcKWjQ

[Georgia Center for Diabetes Translation Research @GCDTR]

Young Hispanic & Non-Hispanic Black adults are the fastest-growing group with T1D in the U.S., yet face major gaps in diabetes technology access. A new study coauthored by GCDTR’s Ashby Walker tests a CHW model addressing both social needs and T1D.
https://t.co/uqIvWjnblK

[Georgia Center for Diabetes Translation Research @GCDTR]

A recent review published in JAMA authored by GCDTR’s @JacobsenLM and Desmond A. Schatz highlights key advances in understanding autoimmune mechanisms, early detection, and evolving treatment strategies.
https://t.co/lJxS36s3T5

[Emory Global Diabetes Research Center @egdrc]

Congratulations to Francisco Pasquel on his appointment as Section Chief of Endocrinology, Metabolism, & Lipids at Emory University Hospital Midtown. A leader across Emory Global Diabetes Research Center & @GCDTR, advancing diabetes care & research.

[Georgia Center for Diabetes Translation Research @GCDTR]

A recent study co-authored by GCDTR’s Roy W Beck @JaebCenter examines how CGM metrics relate to severe hypoglycemia in type 1 diabetes. Hypoglycemia measures were strongly associated with events, but prediction remained limited.

https://t.co/xsP7dxem5G

[Georgia Center for Diabetes Translation Research @GCDTR]

A recent study coauthored by GCDTR researchers and @JaebCenter studied the impact of inhaling Technosphere insulin for youth with type 1 diabetes. In a multicenter study, inhaled insulin produced smaller post-meal glucose excursions and lower peak glucose. https://t.co/nUpXPZuGFe

[Georgia Center for Diabetes Translation Research @GCDTR]

In case you missed it: Watch the GCDTR Virtual Speaker Series featuring Stefano Del Prato, MD, titled Can type 2 diabetes truly go into remission? as he shared the evidence, clinical realities, and future of diabetes remission.
https://t.co/1qur4LFbMz

[Georgia Center for Diabetes Translation Research @GCDTR]

In a recent webinar, “The Central Role of Weight Management in the Care of People with Type 2 Diabetes,” by Dr. Juan Frias where he shared how obesity drives T2DM & related complications, why early weight management should be a primary treatment goal. https://t.co/1DSnQ2wqUi

[Georgia Center for Diabetes Translation Research @GCDTR]

In the recent GCDTR webinar, @ADA_DiabetesPro Roadmap to a World Free from Diabetes, by @ChuckatADA & Dr. Rita Kalyani shared the roadmap, applying research, advocacy, education, & connection to diabetes care, access, nutrition, obesity, & primary care. https://t.co/HycbCIQeYk

[Georgia Center for Diabetes Translation Research @GCDTR]

A recent study coauthored by GCDTR’s Roy W Beck @JaebCenter studied data from 647 technosphere insulin users vs 1,830 controls & found zero lung cancer cases, 0.16% COPD/emphysema/bronchitis vs 1.48% in controls, a reassuring safety profile @UWMedicine
https://t.co/4kXeSgNIXp

[Georgia Center for Diabetes Translation Research @GCDTR]

A recent study coauthored by GCDTR’s Roy W Beck @JaebCenter shows Control-IQ+, an automated insulin system,benefits adults with type 2 diabetes across diverse populations. Key findings are 0.9% HbA1c reduction, 14% higher time-in-range. https://t.co/GVuFGAFRHy